These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 579055)

  • 61. Pharmacokinetics of quinidine in male patients. A population analysis.
    Verme CN; Ludden TM; Clementi WA; Harris SC
    Clin Pharmacokinet; 1992 Jun; 22(6):468-80. PubMed ID: 1587058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of cimetidine on the pharmacokinetics of quinidine and lidocaine in the rat.
    Fruncillo RJ; DiGregorio GJ; Soll A
    J Pharm Sci; 1983 Jul; 72(7):826-8. PubMed ID: 6886994
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between in-vivo and in-vitro tissue-to-plasma unbound concentration ratios (Kp,f) of quinidine in rats.
    Harashima H; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Pharmacol; 1984 May; 36(5):340-2. PubMed ID: 6145776
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stereoselective renal tubular secretion of quinidine and quinine.
    Notterman DA; Drayer DE; Metakis L; Reidenberg MM
    Clin Pharmacol Ther; 1986 Nov; 40(5):511-7. PubMed ID: 3769382
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacobiodyn; 1986 Feb; 9(2):132-8. PubMed ID: 3712213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of age on the hepatic clearance of propranolol in rats.
    Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
    J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of alpha 1-acidglycoprotein on myocardial uptake and pharmacodynamics of quinidine in perfused rat heart.
    Huang JL; Morgan DJ
    Biochem Pharmacol; 1993 Nov; 46(10):1705-11. PubMed ID: 8250956
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.
    Abraham I; Ueda CT
    J Pharm Sci; 1984 Apr; 73(4):452-6. PubMed ID: 6726627
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Investigation of digoxin, quinidine, and disopyramide interactions in rats utilizing parotid saliva, blood, and other tissues.
    DiGregorio GJ; Piraino AJ; Ruch EK; Basseches PJ
    J Pharm Sci; 1982 Feb; 71(2):211-3. PubMed ID: 7062248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits.
    Ueda CT; Nickols JG
    J Pharm Sci; 1980 Dec; 69(12):1400-3. PubMed ID: 7463324
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dose-dependent pharmacokinetics of probenecid in the rat.
    Emanuelsson BM; Paalzow LK
    Biopharm Drug Dispos; 1988; 9(1):59-70. PubMed ID: 3342285
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relation between serum quinidine levels and renal function. Studies in normal subjects and patients with congestive failure and renal insufficiency.
    Bellet S; Roman LR; Boza A
    Am J Cardiol; 1971 Apr; 27(4):368-71. PubMed ID: 5572580
    [No Abstract]   [Full Text] [Related]  

  • 76. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
    Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
    Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
    Chapron DJ; Mumford D; Pitegoff GI
    Arch Intern Med; 1979 Mar; 139(3):363-5. PubMed ID: 426582
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparative study of the pharmacokinetics of quinidine.
    Neff CA; Davis LE; Baggot JD
    Am J Vet Res; 1972 Jul; 33(7):1521-5. PubMed ID: 5039523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.